<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-292</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ ТЕХНОЛОГИЯ И НАНОТЕХНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL TECHNOLOGY AND NANOTECHNOLOGY</subject></subj-group></article-categories><title-group><article-title>СТРАТЕГИЯ СОЗДАНИЯ РЕЦЕПУТР С УЛУЧШЕННОЙ БИОДОСТУПНОСТЬЮ</article-title><trans-title-group xml:lang="en"><trans-title>FORMULATION STRATEGIES FOR ENHANCED TOPICAL BIOAVAILABILITY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смолл</surname><given-names>У.</given-names></name><name name-style="western" xml:lang="en"><surname>Small</surname><given-names>W.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>«Крода Европа Лимитед»</institution></aff><aff xml:lang="en"><institution>Croda Europ Ltd.</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>09</day><month>01</month><year>2019</year></pub-date><volume>0</volume><issue>3</issue><fpage>76</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смолл У., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Смолл У.</copyright-holder><copyright-holder xml:lang="en">Small W.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/292">https://www.pharmjournal.ru/jour/article/view/292</self-uri><abstract><p>В этой статье описаны некоторые способы доставки активных ингредиентов с точки зрения скорости их проникновения и конечного распределения в коже, которые можно регулировать с помощью состава рецептуры. Каждый ингредиент в составе рецептуры в той или иной мере имеет потенциал воздействия на доставку активного компонента, влияя на растворимость активного вещества и на его взаимодействие с кожей, а так же на рецептуру по мере того, как она претерпевает различные фазовые изменения на коже. Поэтому исключительно важно рассмотреть роль каждого ингредиента в рецептуре для оптимизации доставки активного ингредиента.</p></abstract><trans-abstract xml:lang="en"><p>This article has described some of the ways in which the delivery of an active ingredients, in terms of there rate of permeation and location within the skin, can be controlled through formulation design. Every ingredient in the formulation possesses the potential to have some effect on the delivery of an active ingredient, either through its effect on the solubility of the active, its interaction with the skin, or on the formulation as it undergoes various phase changes on the skin. It is therefore important to consider the role of every ingredient in the formulation to optimize a delivery of the active ingredient.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>биодост упность</kwd><kwd>кожа</kwd><kwd>доставка</kwd><kwd>проникновение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bioavailability</kwd><kwd>skin</kwd><kwd>delivery</kwd><kwd>penetration</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
